Clinical trial
Prospective Outcomes Study: Vectra® DA Guided Care Compared to Usual Care
NCT02832297 is registered in ClinicalTrials.gov with Crescendo Bioscience as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Prospective Outcomes Study: Vectra® DA Guided Care Compared to Usual Care
- Lead sponsor
- Crescendo Bioscience
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- June 30, 2016
- Completion date
- August 31, 2022
- Enrollment
- 318 (estimated)
- Sites
- 40
Conditions
As the registry lists them; a condition with its own page is linked.